Low Dose Oxytocin Protocol Made No Difference in Quantitative Blood Loss in Elective Caesarean Sections; a Single Center, Retrospective Cohort Study
Abstract
The use of oxytocin after vaginal and cesarean deliveries is considered standard of care and reduces blood loss by 40-50%. 1 However, no definitive data exists on the optimal intraoperative dosing strategy for patients undergoing cesarean delivery (CD) to optimize blood loss and reduce unwanted side effects. This study aimed at comparing quantitative blood loss (QBL) after elective CD between patients receiving a high dose, non-protocolized oxytocin strategy (Group H) versus patients receiving a newly implemented, low-dose oxytocin protocol (Group L) over a seven-month period at a single academic institution.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2022
- Accession Number
- AD1170968
Entities
People
- Alyssa Zuehl
- Brian Baxter
- Courtney R. Hood
Organizations
- 59th Medical Wing